Mark Leiser is a freelance writer based in New Jersey.
Related Articles
Torsemide or Furosemide After Discharge in Patients Hospitalized with HF
November 2, 2011
Clinical question: Is there a mortality difference in patients discharged on torsemide versus furosemide after heart failure hospitalization? Background: Torsemide has been thought to be superior to...
Risk and Benefit of Secondary Prevention with Aspirin Versus P2Y12 Inhibitor in CAD Patients
November 2, 2011
Clinical question: In patients with coronary artery disease (CAD), what is the difference in risk and benefit between secondary prevention with aspirin (ASA) versus a P2Y12 inhibitor? Background:...
Time to Benefit of SGLT-2 Inhibitors Among Patients with HF
November 2, 2011
Clinical question: What is the time to benefit for patients with heart failure (HF) and prescribed a sodium-glucose cotransporter-2 (SGLT-2) inhibitor? Background: SGLT-2 inhibitors are an effective...
Time to Rethink AF Treatment: Prolonged Benefits of Cryoballoon Ablation
November 2, 2011
Clinical question: Does initial therapy with catheter cryoballoon ablation reduce progression to persistent atrial fibrillation (AF) in patients with symptomatic, paroxysmal AF when compared to...